Officials of International Networks at Indiana University (IN@IU) and the National Institute of Information and Communications Technology (NICT) of Japan signed a memorandum of understanding (MOU) in Hong Kong at the 42nd Asia Pacific Advanced Network (APAN) meeting. The document states that they will continue to work together on sustaining network performance, supporting research and science… Read more »
Entries by Steve Martin
ASK THE TECH MANAGER: Katherine Moynihan discusses when to disclose an invention to IURTC and how to strengthen the disclosure
Q: When should an inventor disclose an invention to IURTC? A: To preserve patent protection in the United States and foreign markets, IURTC must submit a patent application before the invention is publicly disclosed. This includes prior to a poster or oral presentation at a conference, before an abstract is placed online, before a manuscript… Read more »
IURTC licenses cell lines to Canadian life sciences firm
Indiana University Research and Technology Corp. has licensed cells developed at the Indiana University School of Medicine. to Applied Biological Materials Inc., based in Richmond, British Columbia, Canada. Academic, clinical and industrial researchers who study therapies to prevent or treat cancer, autoimmune diseases, blood diseases and metabolic disease can use the myeloid-derived cells to conduct experiments, including… Read more »
Arrhythmotech receives $1.47 million grant
Arrhythmotech LLC, which was launched through the Spin Up program at Indiana University Research and Technology Corp., has received a two-year STTR Phase II grant worth $1,472,476 from the National Institutes of Health. Dr. Peng-Sheng Chen, company co-founder, said the grant will be used on new methods to study patients who are affected by atrial fibrillation. “The… Read more »
U.S. FDA accepts ApeX Therapeutics application to test lead drug candidate
ApeX Therapeutics, which has received an investment from the Innovate Indiana Fund and licenses technology through Indiana University Research and Technology Corp., has had its Investigational New Drug (IND) application accepted by the U.S. Food and Drug Administration. The company will conduct clinical testing of its lead drug candidate, APX3330, in pancreatic cancer. Mark… Read more »
IURTC licenses School of Medicine cell technology to U.K. company
Axol Bioscience Ltd., based in Cambridgeshire, U.K., has licensed technology developed at the Indiana University School of Medicine. The license agreement with Indiana University Research and Technology Corp. is for technology that creates cells found on the interior of blood vessels. It was developed by Dr. Mervin C. Yoder and Nutan Prasain, Ph.D. “We developed… Read more »
IU-related companies at 2016 Innovation Showcase: NERx BioSciences
Several companies with ties to Indiana University, IURTC and Innovate Indiana participated in the 2016 Innovation Showcase on July 13-14. One was NERx BioSciences, which is commercializing technology discovered at the IU School of Medicine. We spoke with Katherine Pawelczak, VP of Research. “We came to Innovation Showcase to establish our network within the state and… Read more »
IU-related companies at 2016 Innovation Showcase: Critique
Several companies with ties to Indiana University, IURTC and Innovate Indiana participated in the 2016 Innovation Showcase on July 13-14. One was Critique, which was co-founded by Matthew Callison and Tiffany Roman, doctoral candidates in the IU School of Education. “We are looking for others with an interest in our pure feedback platform for higher… Read more »
IU-related companies at 2016 Innovation Showcase: What Friends Do
Several companies with ties to Indiana University, IURTC and Innovate Indiana participated in the 2016 Innovation Showcase on July 13-14. One was What Friends Do, which has received investments from the Innovate Indiana Fund. We spoke with Jen DeMotte, Director of Customer Experience. “Our site is running. We are looking to grow and market, so… Read more »
IU-related companies at 2016 Innovation Showcase: Xylogenics
Several companies with ties to Indiana University, IURTC and Innovate Indiana participated in the 2016 Innovation Showcase on July 13-14. One was Xylogenics, which is commercializing technology discovered at the Indiana University School of Medicine. We spoke with Matt Kelker, Chief Scientific Officer. “We are attending Innovation Showcase because we want to gain exposure to… Read more »